Release Date: March 1, 2008
Expiration Date: August 15, 2009
Program Overview
The goal of this program is to offer clinicians the opportunity to review obstacles to optimal osteoporosis care
and the most current approaches in improving outcomes for patients with osteoporosis. This program will also
highlight the latest clinical trial data in osteoporosis treatment.
Target Audience
This program is intended for clinical practitioners and clinical investigators involved in the management of osteoporosis.
Program Objectives
At the conclusion of this program, participants should be able to:
Discuss suboptimal diagnosis and treatment rates for osteoporosis and the clinical impact of fractures
Recognize the differentiating attributes of the treatment armamentarium in osteoporosis
Identify ways to maximize treatment adherence/persistence and minimize fracture risk
Evaluate clinical trial data of novel agents in preventing subsequent fractures
Physician Accreditation
Medical Education Resources, Inc. is accredited by the Accreditation
Council for Continuing Medical Education (ACCME) to sponsor
continuing medical education for physicians.
Credit Designation Statement
Medical Education Resources, Inc. designates this educational
activity for a maximum of 2.0 AMA PRA Category 1 credit(s)™ Physicians should only claim credit commensurate with the extent
of their participation in the activity.
Disclosure of Financial Interests
In accordance with the Accreditation Council for Continuing Medical Education Standards for Commercial
Support, the faculty for this activity have been asked to complete a Conflict of Interest Disclosure form.
Disclosure is required to be provided to attendees or participants.
The following faculty members
disclosed program- or content-related
financial affiliations:
Felicia Cosman, MD
Dr. Cosman has received research/grant support from Eli
Lilly and Company. She serves as a consultant for Novartis Pharmaceuticals Corporation, Eli Lilly and Company, Merck & Co., Inc., Pfizer, and Roche, and is on the Speakers Bureau for Eli Lilly and Company, Merck & Co., Inc., and Roche.
Nelson B. Watts, MD
Dr. Watts has received research/grant support from
Amgen Inc., Eli Lilly and Company, MicroMRI,
Novartis Pharmaceuticals Corporation, Procter & Gamble, Radius, sanofi-aventis, and Solvay. He serves as
a consultant for Amgen Inc., Eli Lilly and Company, Kyphon, Novartis Pharmaceuticals Corporation, Procter
& Gamble, Roche, and sanofi-aventis. Dr. Watts has received honoraria for lectures from the following
companies, but is not a member of any formal speakers bureau: Amgen Inc., Novartis Pharmaceuticals
Corporation, Procter & Gamble, and sanofi-aventis.
Michael R. McClung, MD
Dr. McClung has received research/grant support from Amgen Inc., Eli Lilly and Company, Novartis
Pharmaceuticals Corporation, Procter & Gamble, and Roche. He is also a consultant for these same
companies, in addition to sanofi-aventis.
Kenneth W. Lyles, MD
Dr. Lyles has received research/grant support from Novartis Pharmaceuticals Corporation, The Alliance
for Better Bone Health, and Amgen Inc. He serves as a consultant for Novartis Pharmaceuticals
Corporation, Procter & Gamble, Merck & Co., Inc., Amgen Inc., GTx, and Bone Medical Limited. Dr. Lyles is
the use patent inventor of "Methods for preventing or reducing secondary fractures after hip fracture, US
Patent Application 20050272707, and the provisional patent application inventor for "Medication Kits and
Formulations for Preventing, Treating or Reducing Secondary Fractures After Previous Fracture.
Dr. Lyles knowingly includes in his educational session the discussion of off-label or investigative uses of commercial products.
Printer settings may vary. Please use landscape layout option.
Faculty
Chairperson - Felicia Cosman, MD Professor of Clinical Medicine
Columbia University College of Physicians and Surgeons
New York, New York
Medical Director,
Clinical Research Center
Helen Hayes Hospital
West Haverstraw, New York
Nelson B. Watts, MD Professor of Medicine
University of Cincinnati
College of Medicine
Director, University of Cincinnati Bone Health and
Osteoporosis Center
Cincinnati, Ohio
Michael R. McClung, MD Department of
Medical Education
Providence Portland
Medical Center
Director, Oregon
Osteoporosis Center
Portland, Oregon
Kenneth W. Lyles, MD Professor of Medicine
Vice Chair for
Clinical Research
Director, Medicine
Site-Based Research
Duke University
School of Medicine
VA Medical Center
Durham, North Carolina
